Prognostic Interest of Vasorin in Septic Shock
Key facts
- Who runs it
- Centre Hospitalier Universitaire, Amiens
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 3 Jul 2023
- Ended
- 29 Mar 2025
- Type of study
- Interventional
- Treatments tested
- Blood sampling
- Record updated
- 27 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age ≥18 years old
- Hospitalized in intensive care or medical resuscitation units
- With a septic shock state defined by 2 mmol/l lactate sepsis, requiring vasopressors to maintain mean blood pressure 65 mmHg (despite adequate vascular filling)
- Whether or not they have developed AKI
- Patient/family information and collection of non opposition
Who cannot take part
- Patients with chronic respiratory failure
- Pregnant women
- Patients in palliative care
- Information for the patient/someone close and collection of his opposition
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In septic shock, the intensity and duration of low blood pressure can lead to a critical reduction in renal tissue perfusion and lead to the onset of more or less severe Acute Kidney Injury (AKI). Vasorin (Vasn) is a protein strongly expressed in large vessels and kidneys, whose functions are still poorly known. Previous experimental studies show that Vasn is associated with decreased Angiotensin II concentrations, a vessel contractility defect and early mortality.
Read full original descriptionShow less
The investigators hypothesize that Vasn (the potential direct regulator of blood pressure) would be an early biomarker predicting the severity of AKI post septic shock, which may be associated with mortality from septic shock or lead to longer-term Chronic Renal Failure (CKD).
Treatments tested
- Blood sampling
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 March 2026